ARCHITECT I2000 ANALYZER
Report
- Report Number
- 1628664-2008-00022
- Event Type
- Other
- Date Received
- January 24, 2008
- Date of Event
- January 4, 2008
- Report Date
- January 4, 2008
- Manufacturer
- ABBOTT MANUFACTURING, INC.
- Product Code
- CDZ
- PMA / PMN Number
- K983212
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- UNKNOWN
Narratives
(B)(4). INVESTIGATION SUMMARY: THE ACCOUNT STATED THEY WERE RECEIVING INCONSISTENT BHCG RESULTS. CUSTOMER STATED THAT THEY HAD NO PROBLEMS WITH OTHER ASSAYS. THE COMPLAINT TEXT INDICATES A PHYSICIAN QUESTIONED THE RESULT ON THE FIRST PT, AS THE PREVIOUS RESULT WAS MUCH HIGHER. NO IMPACT TO PT MGMT WAS REPORTED. PER THE COMPLAINT TEXT THE CUSTOMER'S STAT PROBE HAS NEVER BEEN REPLACED. THE CSS INSTRUCTED THE CUSTOMER TO REPLACE AND CALIBRATE THE STAT PROBE AND TO ALSO REPLACE ALL 6 WASH ZONE PROBES. THE CUSTOMER PERFORMED THE REQUESTED TROUBLESHOOTING HOWEVER THE CUSTOMER STILL EXPERIENCED AN ISSUE NEAR THE HIGH LIMIT OF THE ASSAY. THE CUSTOMER LAST CALIBRATED THE ASSAY (B)(6)2008 USING REAGENT LOT NUMBERS (B)(4) AND (B)(4).AND CALIBRATOR LOT NUMBERS (B)(4). AND (B)(4). THE CSS INSTRUCTED THE CUSTOMER TO LOAD THE ROUTINE BHCG ASSAY TO CHECK THE PERFORMANCE OF THE ASSAY. THE COMPLAINT TEXT STATES THE CUSTOMER PERFORMED THE REQUESTED TROUBLESHOOTING BUT DID NOT GET RESULTS IN THE RANGE OF THE HIGH LIMIT. THE COMPLAINT INDICATED THE LOW AND MIDDLE VALUES RECOVERED WERE ACCEPTABLE. THE CSS WAS TO FOLLOW-UP WITH THE CUSTOMER. THIS IS AN INITIAL REPORT. AN INVESTIGATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE. END OF REPORT.
THE CUSTOMER STATES THAT THEY ARE HAVING ISSUES WITH REPRODUCIBILITY WHEN TESTING PTS WITH THE ARCHITECT BHCG ASSAY. THE CUSTOMER STATES THAT THE STAT BHCG ASSAY GENERATED A RESULT OF 175,000 MIU/ML FOR ONE PT, WHICH TESTED 14,900 MIU/ML ON A SAMPLE DRAWN 2 DAYS LATER THAT WAS QUESTIONED BY A PHYSICIAN. THIS SAMPLE WAS REPEATED YIELDING A RESULT OF 15,000 MIU/ML. A RERUN OF THE SAMPLE DILUTED 1:15 GENERATED A RESULT OF 136,000 MIU/ML. NO IMPACT TO PT MGMT WAS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ARCHITECT I2000 ANALYZER | CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY ANALYZER | CDZ | ABBOTT MANUFACTURING, INC. | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NI | Other | (B)(4) |